Segment reporting (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2024
USD ($)
|
Jun. 30, 2024
USD ($)
|
Mar. 31, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Jun. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 30, 2024
USD ($)
segment
|
Sep. 30, 2023
USD ($)
|
|
| Segment reporting | ||||||||
| Number of reportable segments | segment | 1 | |||||||
| Revenue | $ 40,901 | $ 7,319 | $ 174,810 | $ 60,050 | ||||
| Total operating expenses | (55,581) | (53,952) | (170,051) | (149,935) | ||||
| Operating (loss)/profit | (14,680) | (46,633) | 4,759 | (89,885) | ||||
| Interest income | 2,096 | 2,149 | 4,817 | 4,368 | ||||
| Interest expense | (1,109) | (1,635) | ||||||
| Gain on bargain purchase | 22,049 | |||||||
| Remeasurement on bargain purchase | 106 | |||||||
| Other income (expense), net | (3,093) | (324) | (2,657) | (494) | ||||
| Income tax expense | (831) | (687) | (1,883) | (1,992) | ||||
| Segment and consolidated net (loss)/profit | (17,617) | $ 69,521 | $ (48,503) | (45,601) | $ (21,389) | $ 1,036 | 3,401 | (65,954) |
| Research | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (2,954) | (4,197) | (10,392) | (9,570) | ||||
| CMC and Quality | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (15,073) | (17,350) | (44,006) | (43,958) | ||||
| Biomarkers | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (1,196) | (980) | (6,482) | (3,432) | ||||
| Development and Compliance | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (11,279) | (13,128) | (38,765) | (32,165) | ||||
| Infrastructure management and facilities | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (7,951) | (7,491) | (23,779) | (20,981) | ||||
| Commercial planning | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (4,404) | (550) | (10,849) | (1,976) | ||||
| Support functions | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | (9,247) | (8,643) | (30,321) | (37,278) | ||||
| Other | ||||||||
| Segment reporting | ||||||||
| Total operating expenses | $ (3,479) | $ (1,613) | $ (5,458) | $ (575) | ||||
| X | ||||||||||
- Definition In a business combination bargain purchase, this element represents the amount of loss recognized by the entity as a result of remeasuring the purchase consideration or identified assets and liabilities during the measurement period. No definition available.
|
| X | ||||||||||
- Definition In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income, amortization of premium and accretion of discount on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale); classified as operating. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|